ArticleACS omega2026
Improvement of the Stability of Functionalized PVA Nanofibers for Sensitive Compound Incorporation by Gentle Freeze-Thaw Treatment.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in tissue engineering focus on enhancing the biological performance of nanofibrous materials that mimic the extracellular matrix. These materials provide mechanical stability and form nanofibrous membranes that support cell adhesion, migration, and growth. Their functionality can be further improved by incorporating bioactive compounds, especially in water-soluble polymer-based nanofibers, enabling controlled release. However, a major limitation is the "burst release" effect, where more than 90% of the embedded substances are released within the first 24 h. The second challenge is the stabilization of these water-soluble systems. The most commonly used chemical crosslinking methods require the addition of chemical agents (crosslinkers) that are potentially toxic and may lead to structural and chemical changes in the nanofibrous materials, while also causing denaturation of the incorporated bioactive compounds. This study presents the development of functionalized nanofibers based on water-soluble poly-(vinyl alcohol) (PVA), produced by an advanced alternating current (AC) electrospinning method, and their subsequent stabilization using a non-toxic Freeze-Thaw (FT) method. This physical stabilization technique avoids chemical crosslinkers and instead induces crystallinity through polymer chain reorganization, reducing solubility while preserving structural integrity. The impact of FT stabilization on the physicochemical properties and solubility of PVA nanofibers was evaluated, along with its effect on the release profile of human platelet lysate (PL), a growth factor-rich additive. The results show that FT treatment effectively stabilizes PVA nanofibers and significantly slows down the release of incorporated PL. Specifically, the solubility of neat PVA nanofibers after 10 FT cycles under thawing at +4 °C decreased by 19.5%, whereas in PVA + PL nanofibers the reduction in PVA solubility under the same conditions reached 12.2%. The release of PL itself slowed by 18.2% after 10 FT cycles. Changes in crystallinity were also observed in the FT-treated materials. This approach offers a promising platform for developing safe, functional nanofibrous materials for chronic wound treatment and skin regeneration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.